Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Core: To compare the efficacy of two regimens of deferasirox administration (starting doses of 5 and 10 mg/kg/day) in patients with non-transfusion-dependent thalassemia based on change in LIC from baseline after one year of treatment compared to placebo treated patients. Extension: To evaluate the number of patients reaching LIC<5mg Fe/g dw and to evaluate the long-term safety of deferasirox administration in patients with non-transfusion-dependent thalassemia
Critère d'inclusion
- Chronic iron overload in patients with non-transfusion-dependent thalassemia